Mengsi Zhang

Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Construction of a prognostic model based on palmitoylation-related lncRNAs for assessing drug benefits in breast cancer.

Construction of a prognostic model based on palmitoylation-related lncRNAs for assessing drug benefits in breast cancer.

Journal: Frontiers in immunology

Published: June 30, 2025

Novel therapeutic strategies for targeting fatty acid oxidation in cancer.

Novel therapeutic strategies for targeting fatty acid oxidation in cancer.

Journal: Biomarker research

Published: May 29, 2025

Inhibition of CPT1A activates the cGAS/STING pathway to enhance neutrophil-mediated tumor abrogation in triple-negative breast cancer.

Inhibition of CPT1A activates the cGAS/STING pathway to enhance neutrophil-mediated tumor abrogation in triple-negative breast cancer.

Journal: Cancer letters

Published: May 22, 2025

Plasma DNMT1 Activity for Assessing Tumor Burden and Predicting Neoadjuvant Therapy Response in Breast Cancer.

Plasma DNMT1 Activity for Assessing Tumor Burden and Predicting Neoadjuvant Therapy Response in Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 17, 2025

Endothelial cell-derived SDF-1α elicits stemness traits of glioblastoma via dual-regulation of GLI1.

Endothelial cell-derived SDF-1α elicits stemness traits of glioblastoma via dual-regulation of GLI1.

Journal: Theranostics

Published: December 15, 2024

Tumor PD-L1 induces β2m ubiquitylation and degradation for cancer cell immune evasion.

Tumor PD-L1 induces β2m ubiquitylation and degradation for cancer cell immune evasion.

Journal: Cell research

Published: November 13, 2024

Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial.

Intestinal Subtype as a Biomarker of Response to Neoadjuvant Immunochemotherapy in Locally Advanced Gastric Adenocarcinoma: Insights from a Prospective Phase II Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 29, 2024

Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas.

Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas.

Journal: Signal transduction and targeted therapy

Published: February 23, 2021

Nanog promotes stem-like traits of glioblastoma cells.

Nanog promotes stem-like traits of glioblastoma cells.

Journal: Frontiers in bioscience (Landmark edition)

Published: October 13, 2020

Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling.

Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling.

Journal: Frontiers in cell and developmental biology

Published: August 20, 2020

Autofluorescence of NADH is a new biomarker for sorting and characterizing cancer stem cells in human glioma.

Autofluorescence of NADH is a new biomarker for sorting and characterizing cancer stem cells in human glioma.

Journal: Stem cell research & therapy

Published: July 17, 2019

A novel photoelectrochemical strategy based on an integrative photoactive heterojunction nanomaterial and a redox cycling amplification system for ultrasensitive determination of microRNA in cells.

A novel photoelectrochemical strategy based on an integrative photoactive heterojunction nanomaterial and a redox cycling amplification system for ultrasensitive determination of microRNA in cells.

Journal: Biosensors & bioelectronics

Published: July 05, 2019

Showing 1-12 of 16

Last Updated: 09/26/2026